Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

Blood

Volumn 88, Issue 8, 1996, Pages 2819-2825

  Anderlini, Paolo ^a   Przepiorka, Donna ^a   Champlin, Richard ^a   Körbling, Martin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANALGESIC AGENT; CYTOKINE; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; MAGNESIUM; OPIATE; POTASSIUM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; BLOOD CLOTTING; BONE PAIN; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; DRUG SAFETY; FATIGUE; HEADACHE; HEMATOPOIESIS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MYELODYSPLASTIC SYNDROME; NAUSEA; NEUTROPENIA; NEUTROPHIL; NORMAL HUMAN; OSTEOPENIA; OSTEOPOROSIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT;

EID: 0029976860     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.2819.bloodjournal8882819     Document Type: Review

References (77)

1. Zsebo KM, Cohen AM, Murdock DC, Boone TC, Inoue H, Chazin VR, Hines D, Souza LM: Recombinant human granulocyte colony-stimulating factor: Molecular and biological characterization. Immunobiology 172:175, 1986
2. Weite K, Bonilla MA, Gillio AP,Boone TC, Potter GK, Gabrilove JL, Moore MAS, O'Reilly RJ, Souza LM: Recombinant human G-CSF: Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 165:941, 1987
3. Demetri GD, Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 78:2791, 1991
4. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM: Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56:809, 1987
5. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28, 1992
6. The American Society of Clinical Oncology: American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 12:2471, 1994
7. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift RC, Lilleby K, Williams B, Storb R, Donnall Thomas E, Buckner CD: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883, 1993
8. Caspar CB, Seger RA, Burger J, Gmur J: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 81:2866, 1993
9. Jendiroba DB, Lichtiger B, Hester JP, O'Brien S, Kantarjian H, Reddy V, Freireich EJ, Anaissie E: Evaluation and comparison of three mobilization methods for granulocyte collection. Blood 86:609a, 1995 (abstr, suppl 1)
10. Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82:1981, 1993
11. Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
12. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
13. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
14. Russell JA, Luider J, Weaver M, Brown C, Selinger S, Railton C, Karlsson L, Klassen J: Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 15:111, 1995
15. Azevedo WM, Aranha FJP, Gouvea JV, Vigorito AC, Marques JFC Jr, Eid KAB, Azevedo AM, Souza CA: Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 16:647, 1995
16. Goldman J: Peripheral blood stem cells for allografting. Blood 85:1413, 1995
17. Neupogen. Thousand Oaks, CA, Amgen, 1994 (package insert)
18. de Haas M, Kerst JM, van der Schoot C, Calafat J, Hach CE, Nuijens JH, Roos D, van Oers RHJ, von dem Borne EGK: Granulocyte colony-stimulating factor administration to healthy volunteers:analysis of the immediate activating effect on circulating neutrophils. Blood 84:3885, 1994
19. Cebon J, Layton JE, Maher D, Morstyn G: Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 86:265, 1994
20. Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, Kamachi S: Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73:117, 1989
21. Pauksen K, Elfman L, Ulfgren AK, Venge P: Serum levels of granulocyte colony-stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 88:256, 1994
22. Anderlini P, Körbling M, Miller P, Sundberg J, Champlin R, Chan KW: Allogeneic peripheral blood progenitor cell (PBPC) transplantation: Collection of filgrastim-mobilized PBPCs from normal donors weighing 40 kg or less. Bone Marrow Transplant 17:S57, 1996(suppl 1)
23. Price TH, Chatta GS, Dale DC: The effect of recombinant granulocyte colony-stimulating factor (G-CSF) on neutrophil kinetics in normal human subjects. Blood 80:350a, 1992 (abstr, suppl 1)
24. Chatta GS, Price TH, Allen RC, Dale DC: Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 84:2923, 1994
25. Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL: Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76:36, 1990
26. Baer MR, Bernstein SH, Brunetto VL, Heinonen K, Mrózek K, Swann VL, Minderman H, Block AMW, Pixley LA, Christiansen NP, Fay JW, Barcos M, Rustum Y, Herzig GP, Bloomfield CD: Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia. Blood 87:1484, 1996
27. Roilides E, Walsh TJ, Pizzo PA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163:579, 1991
28. Tsuruta T, Tani K, Shimane M, Ozawa K, Takahashi S, Tsuchimoto D, Takahashi K, Nagata N, Sato N, Asano S: Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders. Br J Haematol 92:9, 1996
29. Sullivan R, Griffin JD, Simons ER, Schafer AI, Meshulam T, Fredette JP, Maas AK, Gadenne AS, Leavitt JL, Melnyck DA: Effects of recombinant human granulocyte and macrophage colonystimulating factors on signal transduction pathways in human granulocytes. J Immunol 139:3422, 1987
30. Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F: Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74:2144, 1989
31. Hartung T, Döcke WD, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482, 1995
32. Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H, Galanos C, Holsboer F: Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87:900, 1996
33. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura A: Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood 86:2220, 1995
34. Fujisaki T, Otsuka T, Harada M, Ohno Y, Niho Y: Granulocyte colony-stimulating factor mobilizes primitive hematopoietic stem cells in normal individuals. Bone Marrow Transplant 16:57, 1995
35. Schwinger W, Mache C, Urban C, Beaufort F, Töglhofer W: Single dose of filgrastim (rhG-CSF) increses the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant 11:489, 1993
36. Prosper F, Stroncek D, Verfaillie CM: Mobilization of LTC-IC in normal donors treated with G-CSF: Phenotypic analysis of mobilized PBPC. Blood 86:464a, 1995 (abstr, suppl 1)
37. Matsunaga T, Sakamaki S, Kongo Y, Ohi S, Hirayama Y, Niitsu Y: Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 11:103, 1993
38. dim) and lymphoid subsets, and possible predictors of engraftment and graft- versus-host disease. Blood 86:2842, 1995
39. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 84:2795, 1994
40. + blood cells. Blood 86:2500, 1995
41. Tanaka R, Matsudaira T, Tanaka I, Muraoka K, Ebihara Y, Ikebuchi K, Nakahata T: Kinetics and characteristics of peripheral blood progenitor cells mobilized by G-CSF in normal healthy volunteers. Blood 84:541a, 1994 (abstr, suppl 1)
42. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Mather D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437, 1995
43. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N: Filgrastim-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
44. + cell counts. Blood 84:541a, 1994 (abstr, suppl 1)
45. Mc Quaker IG, Hunter AE, Haynes AP, Miflin G, Long SG, Russell NH: Allogeneic PBPCT - A dose ranging study using lenograstim for mobilization. Blood 86:582a, 1995 (abstr, suppl 1)
46. Höglund M, Bengtsson M, Simonsson B, Smedmyr B, Tötterman T: Leukapheresis with peripheral blood progenitor cell (PBPC) harvest in healthy volunteers receiving different doses of Ienograstim - Evidence of a dose response effect. Blood 84:348a, 1994 (abstr, suppl 1)
47. Sato N, Sawada K, Takahashi TA, Mogi Y, Asano S, Koike T, Sekiguchi S: A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp Hematol 22:973, 1994
48. Höglund M, Bengtsson M, Cour-Chabernaud V, Dabouz-Harrouche, Simonsson B, Smedmyr B, Tötterman T: Glycosylated rHuG-CSF is more potent than non-glycosylated rHuG-CSF in mobilisation of peripheral blood progenitor cells (PBPC) in healthy volunteers. Blood 86:464a, 1995 (abstr, suppl 1)
49. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan K, Champlin R, Körbling M: Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedure. Transfusion 36:590, 1996
50. Suzue T, Kawano Y, Takaue Y, Kuroda Y: Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol 22:888, 1994
51. Liles WC, Huang JE, Llewelyn C, Price TH, Dale DC: A comparative trial of granulocyte colony-stimulating factor (G-CSF) and dexamethasone alone and in combination for the mobilization of neutrophils in the peripheral blood of normal human volunteers. Blood 86:609a, 1995 (abstr, suppl 1)
52. Anderlini P, Przepiorka D, Huh Y, Lauppe J, Miller P, Sundberg J, Seong D, Champlin R, Körbling M: Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol 93:940, 1996
53. Hillyer CD, Tiegerman KO, Berkman EM: Increase in circulating colony-forming units-granulocyte-macrophage during largevolume leukapheresis: Evaluation of a new cell separator. Transfusion 31:327, 1991
54. Falanga A, Marchetti M, Oldani E, Giovanelli S, Barbui T: Changes of hemostatic parameters in healthy donors administered G-CSF for peripheral blood progenitor cells (PBPC) collection. Bone Marrow Transplant 17:S72, 1996 (abstr, suppl 12)
55. Kadar JG, Arseniev L, Sosada M, Avenarius HJ, Schnittger K, Diedrich H, Südmeier I, Zaki M, Battmer K, Stangel W, Link H: Prospective study of donor safety in growth factor mobilization and progenitor cell apheresis for allogeneic transplantation. Blood 86:579a, 1995 (abstr, suppl 1)
56. Bishop MR, Tarantolo SR, Schmit-Pokorny K, Cowles K, Bierman PJ, Vose JM, Armitage JO, Pavletic ZS, Jackson J, Zacharias D, Nasrati K, Kessinger A: Mobilization of blood stem cells from HLA-matched related donors with low-dose granulocyte colonystimulating for allogeneic transplantation. Blood 86:463a, 1995 (abstr, suppl 1)
57. Stroncek D, Clay M, Mills B, Oldham F, McCullough J: Experiences of normal individuals treated with granulocyte colonystimulating factor. Blood 84:349a, 1994 (abstr, suppl 1)
58. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
59. Anderlini P, Przepiorka D, Miller P, Sundberg J, Seong J, Champlin R, Körbling M: Safety and tolerability of "high-dose" G-CSF (filgrastim) in normal stem cell donors: A prospective study. Proc Am Soc Clin Oncol 15:269, 1996 (abstr)
60. Weinthal J, Rosenfeld C, Aston S, Hoffman V, Magsamen M: High dose G-CSF stem cell mobilization of normal donors: Efficacy, toxicity and immunophenotypic correlation with age and sex. Blood 86:993a, 1995 (abstr, suppl 1)
61. Gudi R, Krishnamurthy M, Pachter BR: Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain. Ann Intern Med 123:236, 1995
62. Hasenclever D, Sextro M: Safety of alloPBPCT donors: Bio-metrical considerations on monitoring long term risks. Bone Marrow Transplant 17:S28, 1996 (suppl 2)
63. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggiero M, Davis M, Koci B, Hammond W, Gillio A, Weite K: Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (R-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88:723, 1994
64. Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, Touw IP: Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333:487, 1995
65. Imashuku S, Hibi S, Kataoka-Morimoto Y, Yoshihara T, Ikushima S, Morioka Y, Todo S: Myelodysplasia and acute myeloid leukemia in cases of aplastic anemia and congenital neutropenia following G-CSF administration. Br J Haematol 89:188, 1995
66. Kojima S, Tsuchida M, Matsuyama T: Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. N Engl J Med 326:1294, 1992 (letter)
67. Imashuku S, Hibi S, Nakajima F, Mitsui T, Yokoyama S, Kojima S, Matsuyama T, Nakahata T, Ueda K, Tsukimoto I, Hanawa Y, Takaku F: A review of 125 cases to determine the risk of myelodysplasia and leukemia in pediatric neutropenic patients after treatment with recombinant human granulocyte colony-stimulating factor. Blood 84:2380, 1994 (letter)
68. de Planque MM, Bacigalupo A, Würsch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C: Long-term follow-up of severe aplastic anemia patients treated with antithymocyte globulin. Br J Haematol 73:121, 1989
69. Bishop NJ, Williams DM, Compston JC, Stirling DM, Prentice A: Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol 89:927, 1995
70. Purton LE, Lee MY, Torok-Storb B: Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Blood 87:1802, 1996
71. Bortin MM, D'Amaro J, Bach FH, Rimm AA, van Rood JJ: HLA associations with leukemia. Blood 70:227, 1987
72. Ohsaka A: Granulocyte colony-stimulating factor administration and monocyte phenotype. Exp Hematol 24:767, 1996 (letter)
73. Harada M, Nagafuji K, Fujisaki T, Kubota A, Mizuno S, Takenaka K, Miyamoto T, Ohno Y, Gondo H, Kuroiwa M, Okamura T, Inaba S, Niho Y: G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. J Hematother 5:63, 1996
74. Shimoda K, Okamura S, Inaba S, Okamura T, Ohga S, Ueda K, Niho Y: Granulocyte colony-stimulating factor and platelet aggregation. Lancet 341:633, 1993 (letter)
75. Shimoda K, Okamura S, Harada N, Kondo S, Okamura T, Niho Y: Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 91:1310, 1993
76. Parkkali T, Volin L, Sirén MK, Ruutu T, Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant 17:433, 1996
77. Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffmann R, Sheay W, Cody R, Philipp C, Resta D, George M: Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol 24:839, 1996